Evidence map›Paper›PMID 22583600›Full record

ReviewNeurogastroenterology and motility2012

Intestinal barrier function in health and gastrointestinal disease.

M Camilleri, K Madsen, R Spiller, B Greenwood-Van Meerveld, B G Van Meerveld, G N Verne

Erratum issuedOpen access · bronzeAbstract readReview
In one paragraph

Review in Neurogastroenterology and motility, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 450 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
450citing papers in PubMed, 2 pooled it
25.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

450 citing papers in PubMed, 2 syntheses or guidelines pooled it, 858 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Synthetic and systems biotechnology · 2027
    Review
  6. Review
  7. Article
  8. Identification of Ferro-Aging-Related Biomarkers for Ulcerative Colitis Through Integrated Machine Learning, Single-Cell Analysis, and Spatial Transcriptomics.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. A Review on the Molecular Dynamics of EnterotypeInternational journal of molecular sciences · 2026
    Review
  19. Observational
  20. Protective Effect ofJournal of microbiology and biotechnology · 2026
    Article

390 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 3 countries.

M CamilleriClinical Enteric Neuroscience Translational and Epidemiological Research, Mayo Clinic, Rochester, MN, USA.
K Madsen
R Spiller
B Greenwood-Van Meerveld
B G Van Meerveld
G N Verne
Mayo Clinic in Florida · USNIHR Nottingham Digestive Diseases Biomedical Research Unit · GBThe University of Texas Medical Branch at Galveston · USUniversity of Alberta Hospital · CAUniversity of Oklahoma Health Sciences Center · US

Funding

Mechanisms of Altered Gastrointestinal DysfunctionR01DK099052 · NIDDK · UNIVERSITY OF TEXAS MED BR GALVESTON · PI VERNE, GEORGE NICHOLAS, ZHOU, QIQI · 2013 to 2023
$3.0M
Randomized Placebo-Controlled Trial of Glutamine for Patients with IBSR21AT005291 · NCCIH · UNIVERSITY OF TEXAS MED BR GALVESTON · PI VERNE, GEORGE NICHOLAS · 2010 to 2012
$566k
CIHR 93675-1NCCIH NIH HHS R21 AT005291NIDDK NIH HHS R01 DK099052
6 · The paper itself

Abstract

Defects in intestinal barrier function are associated with diseases of the gastrointestinal (GI) tract. There is growing evidence that increases in intestinal permeability plays a pathogenic role in diseases, such as inflammatory bowel disease (IBD) and celiac disease, and functional bowel disorders, such as irritable bowel syndrome (IBS). This review takes a unique translational approach to discuss the physiological and pathophysiological mechanisms involved in the regulation of intestinal barrier function in IBS. The review summarizes the components of the intestinal barrier including the tight junction complex within the epithelium, and the methods used to assess gut permeability both in vitro and in vivo. Throughout the review, the authors have attempted to critically review the latest research from both experimental animal models and human studies to appraise whether intestinal barrier dysfunction is a primary cause of functional GI disorders, such as IBS.…

Indexed as

HumansIntestinal DiseasesIntestinal MucosaIntestinesTight Junctions

Identifiers

PMID22583600
PMCPMC5595063
OpenAlexW1523737655

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.